Sirion Biotech
GermanyWho owns Sirion Biotech?
Sirion Biotech is a German Biotech company, now owned by PerkinElmer, which acquired it in 2021 from Bayern Kapital, High-Tech Gruenderfonds (HTGF) and Creathor Ventures.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Key facts
- ·Fully exited in 2021 to PerkinElmer (Revvity).
- ·Average hold across 3 realized cycles: 14 years.
Ownership history
3 ownership periods · co-invest detected
Bayern Kapital sold SIRION Biotech to PerkinElmer in 2021 after 14 years.
Creathor Ventures sold Sirion Biotech to PerkinElmer in 2021 after 14 years.
High-Tech Gruenderfonds (HTGF) sold SIRION Biotech to PerkinElmer in 2021 after 14 years.
More from Creathor Venture Fund II
Other portfolio companies in the same fund.
Austria
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Sirion Biotech?
Sirion Biotech is now owned by PerkinElmer, which acquired it in 2021 from Bayern Kapital, High-Tech Gruenderfonds (HTGF) and Creathor Ventures.
When did PerkinElmer acquire Sirion Biotech?
PerkinElmer acquired Sirion Biotech in 2021, buying from Bayern Kapital, High-Tech Gruenderfonds (HTGF) and Creathor Ventures.
Who did Sirion Biotech sell to?
Bayern Kapital, High-Tech Gruenderfonds (HTGF) and Creathor Ventures sold Sirion Biotech to PerkinElmer in 2021 (Trade Sale).
Who has owned Sirion Biotech over time?
Sirion Biotech has been through 3 private-equity ownership periods: Bayern Kapital · via Seedfonds Bayern · 2007–2021 · sold to PerkinElmer · (Trade Sale); High-Tech Gruenderfonds (HTGF) · via HTGF I · 2007–2021 · sold to PerkinElmer · (Trade Sale); Creathor Ventures · via Creathor Venture Fund II · 2007–2021 · sold to PerkinElmer · (Trade Sale).